The PL-PFC–amygdala circuit modulates anxiety-like behavior [60], so we speculate that activation of the amygdala ERK–mTORC1–p70S6K pathway contributes to the anxiolytic-like effects of DOP agonists. Here, RPS6KB1 is linked to Anxiety.